Financial Year |
March 31 2023 |
Monetary Funds |
1,961,126,279.89 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
122,339,109.99 |
Accounts Receivable |
169,465,731.57 |
Advances to Suppliers |
12,781,288.56 |
Other Receivables |
1,719,176.55 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
51,738,767.83 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
8,458,271.83 |
Total Current Assets |
2,365,865,969.74 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
107,490,099.13 |
Fixed Assetes |
3,084,529,161.31 |
Under-construction Projects |
25,805,824.07 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
20,275,769.25 |
Oil and Gas Assets |
-- |
Intangible Assets |
407,315,474.53 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
3,159,799.94 |
Deferred Income Tax Assets |
11,299,763.29 |
Other Non-Current Assets |
2,743,092.43 |
Sub-Total of Non-Current Assets |
3,830,097,383.95 |
Total Assets |
6,195,963,353.69 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
88,911,865.28 |
Accounts Payable |
129,584,705.65 |
Accounts Received In Advance |
130,256.91 |
Employee Compensation Payable |
29,453,891.55 |
Taxes Payable |
83,186,260.38 |
Interest Payable |
-- |
Dividend Payable |
5,321,311.32 |
Other payables |
92,969,353.90 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
4,752,858.32 |
Sub-Total of Current Liabilities |
470,467,153.18 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
25,454.09 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
39,914,142.09 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
40,909,967.91 |
Total Liabilities |
511,377,121.09 |
Paid-In Capital(Or Share Stock) |
1,458,374,735.00 |
Capital Surplus |
4,321,908,252.77 |
Surplus Reserve |
135,249,454.68 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-236,512,622.18 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,684,586,232.60 |
Owner's Equity(Stockholder's Equity) |
5,684,586,232.60 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
6,195,963,353.69 |